Keyphrases
Non-associated
75%
Plasmodium Falciparum
63%
Falciparum Malaria
53%
Malaria
52%
Polymorphism
41%
Severe Malaria
33%
Disease Severity
27%
VAR2CSA
25%
Adjuvanted
25%
Plasmodium Vivax
25%
Chondroitin Sulfate
25%
Endothelial Protein C Receptor
25%
Stable Emulsion
25%
Chloroquine Resistance Transporter
25%
Drug Resistance Gene
25%
Blood Group
25%
First-in-human
25%
Tanzania
25%
Vaccine Candidate
25%
Southern Mozambique
25%
Greece
25%
Adverse Events
25%
Receptor Gene
25%
Chloroquine
25%
Transporter Genes
25%
Placenta
25%
Artemether-lumefantrine
25%
Ghanaian children
25%
Heme oxygenase-1 (HO-1)
25%
Southern Taiwan
25%
Voltage-gated Sodium Channel Gene
25%
Knockdown Resistance Gene
25%
Randomised Double-blind Clinical Trial
25%
Genetic Polymorphism
25%
Pregnancy-associated Malaria
25%
Human Genetics
25%
Children's Health
23%
SNP
22%
Disease Groups
19%
Ghanaians
19%
Uncomplicated Malaria
16%
Sequestration
15%
Infected Erythrocytes
15%
Immunology and Microbiology
Haplotype
100%
Plasmodium falciparum
66%
Allele
37%
Single Nucleotide Polymorphism
33%
Artemether
25%
Endothelial Protein C Receptor
25%
Plasmodium vivax
25%
Multidrug Resistance
25%
Placenta
25%
Blood Group
25%
Receptor Gene
25%
Genetic Polymorphism
25%
Chloroquine
25%
Child Health
18%
Erythrocyte
16%
